HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

George P Kim Selected Research

Pancreatic Neoplasms (Pancreatic Cancer)

1/2022N064A (Alliance): Phase II Study of Panitumumab, Chemotherapy, and External Beam Radiation in Patients with Locally Advanced Pancreatic Adenocarcinoma.
1/2020Phase 1 trial of Vismodegib and Erlotinib combination in metastatic pancreatic cancer.
1/2019A Phase II Randomized Trial of Panitumumab, Erlotinib, and Gemcitabine Versus Erlotinib and Gemcitabine in Patients with Untreated, Metastatic Pancreatic Adenocarcinoma: North Central Cancer Treatment Group Trial N064B (Alliance).
5/2017Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX.
8/2015Phase II trial of gemcitabine and tanespimycin (17AAG) in metastatic pancreatic cancer: a Mayo Clinic Phase II Consortium study.
4/2014Should combination chemotherapy serve as the backbone in clinical trials of advanced pancreatic cancer? A pooled analysis of phase II trials of gemcitabine-containing doublets plus bevacizumab.
9/2012A phase 2 trial of ixabepilone plus cetuximab in first-line treatment of metastatic pancreatic cancer.
7/2008Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005).
5/2007Treatment options for hepatobiliary and pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


George P Kim Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 04/2007
9Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 05/2007
8Adenocarcinoma
01/2022 - 07/2008
7Colorectal Neoplasms (Colorectal Cancer)
01/2018 - 11/2005
4Hepatocellular Carcinoma (Hepatoma)
10/2012 - 05/2007
3Carcinoma (Carcinomatosis)
02/2012 - 07/2008
2Nausea
01/2018 - 06/2009
2Fatigue
01/2018 - 08/2012
2Cholangiocarcinoma
05/2012 - 05/2007
2Microsatellite Instability
06/2011 - 03/2007
1Disease Progression
11/2023
1Neuroendocrine Tumors (Neuroendocrine Tumor)
11/2023
1Back Pain (Backache)
01/2018
1Constipation
01/2018
1Hyperglycemia
03/2016
1Hypophosphatemia
03/2016
1Ovarian Neoplasms (Ovarian Cancer)
03/2016
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
07/2015
1Leukemia
04/2014
1Liver Diseases (Liver Disease)
11/2013
1Hypertension (High Blood Pressure)
08/2012
1Anorexia
08/2012
1Obesity
02/2012
1Colonic Neoplasms (Colon Cancer)
06/2011
1Neoplasm Metastasis (Metastasis)
01/2011
1Febrile Neutropenia
06/2009
1Diarrhea
06/2009
1Vomiting
06/2009
1Neutropenia
06/2009
1Paresthesia (Dysesthesia)
06/2009
1Hypersensitivity (Allergy)
06/2008

Drug/Important Bio-Agent (IBA)

9GemcitabineFDA Link
01/2022 - 09/2012
6Oxaliplatin (Eloxatin)FDA LinkGeneric
01/2021 - 11/2005
5Fluorouracil (Carac)FDA LinkGeneric
01/2021 - 04/2007
4Bevacizumab (Avastin)FDA Link
11/2023 - 04/2007
4ErbB Receptors (EGF Receptor)IBA
01/2020 - 11/2005
3Panitumumab (Vectibix)FDA Link
01/2022 - 06/2008
3Irinotecan (Camptosar)FDA LinkGeneric
02/2021 - 06/2009
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2020 - 07/2010
3Leucovorin (Folinic Acid)FDA Link
05/2017 - 04/2007
3Cetuximab (Erbitux)FDA Link
09/2012 - 04/2007
2Docetaxel (Taxotere)FDA Link
01/2021 - 10/2012
2Biomarkers (Surrogate Marker)IBA
01/2020 - 01/2018
2Monoclonal AntibodiesIBA
01/2018 - 06/2008
2Proteins (Proteins, Gene)FDA Link
08/2015 - 06/2011
2Cisplatin (Platino)FDA LinkGeneric
07/2015 - 08/2014
2Alanine Transaminase (SGPT)IBA
11/2013 - 08/2012
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2012 - 07/2010
1temsirolimusFDA Link
11/2023
1Capecitabine (Xeloda)FDA Link
01/2021
1HhAntag691IBA
01/2020
1ontuxizumabIBA
01/2018
1folfirinoxIBA
05/2017
1130-nm albumin-bound paclitaxelIBA
05/2017
1MesothelinIBA
03/2016
1Antimitotic AgentsIBA
03/2016
1Immunoconjugates (Immunoconjugate)IBA
03/2016
1monomethyl auristatin EIBA
03/2016
1PlatinumIBA
03/2016
1Cytotoxins (Cytolysins)IBA
08/2015
1tanespimycin (17AAG)IBA
08/2015
1Carcinoembryonic AntigenIBA
08/2015
1Carboplatin (JM8)FDA LinkGeneric
07/2015
1EverolimusFDA Link
08/2014
1Dihydrotachysterol (AT 10)IBA
07/2014
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
11/2013
1BilirubinIBA
11/2013
1ixabepilone (BMS 247550)FDA Link
09/2012
1cediranib (AZD2171)IBA
08/2012
1Bortezomib (Velcade)FDA Link
02/2012
1Tyrosine Kinase InhibitorsIBA
07/2010
1AntibodiesIBA
06/2008
1Vitamin B 12 (Cyanocobalamin)FDA LinkGeneric
07/2007
1pyrimidineIBA
07/2007
1purineIBA
07/2007
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2007
1Folic Acid AntagonistsIBA
07/2007
1Pemetrexed (MTA)FDA Link
07/2007

Therapy/Procedure

9Therapeutics
01/2021 - 05/2007
8Drug Therapy (Chemotherapy)
01/2022 - 07/2007
4Adjuvant Chemotherapy
08/2015 - 03/2007
3Liver Transplantation
05/2012 - 05/2007
2Neoadjuvant Therapy
01/2021 - 05/2012
2Combination Drug Therapy (Combination Chemotherapy)
04/2014 - 07/2010
1Chemoradiotherapy
01/2022
1Drug Tapering
02/2021
1Induction Chemotherapy
01/2021
1Retreatment
03/2016
1Microspheres (Microsphere)
11/2013
1Radiotherapy
07/2008
1Adjuvant Radiotherapy
07/2008